US Stock MarketDetailed Quotes

NMTC NeuroOne Medical

Watchlist
  • 1.1104
  • -0.0296-2.60%
Close Feb 27 16:00 ET
  • 1.0806
  • -0.0298-2.68%
Post 20:01 ET
34.27MMarket Cap-4.27P/E (TTM)

NeuroOne Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
105.46%208.05K
14.55%-11.01M
8.13%-2.67M
19.72%-2.36M
38.75%-2.18M
-9.08%-3.81M
-71.38%-12.89M
-385.20%-2.9M
-11.52%-2.94M
-10.24%-3.55M
Net income from continuing operations
153.37%1.79M
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
-18.60%-11.86M
-128.12%-3.14M
-25.69%-3.47M
-15.20%-3.52M
Operating gains losses
---389.45K
----
----
----
----
----
--32.14K
----
----
----
Depreciation and amortization
11.03%65.13K
23.85%246.79K
2.59%64.13K
10.80%63.11K
38.69%60.9K
63.44%58.66K
67.99%199.27K
87.03%62.51K
80.78%56.96K
53.90%43.91K
Other non cash items
1,120.59%352.28K
509.67%669.61K
1,962.63%583K
2.15%28.28K
8.70%29.47K
7.80%28.86K
-48.23%109.83K
-78.61%28.27K
2.09%27.68K
1.66%27.11K
Change In working capital
-125.93%-1.94M
60.69%-954.61K
-87.68%-303.79K
-115.04%-22.87K
173.38%232.7K
59.05%-860.65K
-300.11%-2.43M
-108.17%-161.87K
179.58%152.04K
29.75%-317.12K
-Change in receivables
-303.44%-2.19M
-631.44%-176.64K
--233.92K
-32.19%145.09K
89.68%-12.24K
-775.29%-543.4K
120.13%33.24K
--0
484.82%213.95K
-892.25%-118.63K
-Change in inventory
496.71%704.29K
11.12%-908.47K
-300.52%-841.72K
-40.77%-481.76K
209.69%296.98K
159.31%118.03K
-68.60%-1.02M
16.02%-210.16K
-47.27%-342.22K
-3,854.20%-270.75K
-Change in prepaid assets
475.71%21.76K
43.71%47.29K
186.37%45.02K
-8.03%146.3K
0.80%-147.81K
-94.96%3.78K
122.61%32.9K
-66,719.23%-52.12K
758.57%159.08K
16.12%-149K
-Change in payables and accrued expense
-8.92%-478.23K
105.65%83.21K
157.94%259K
38.16%167.5K
107.76%95.76K
4.60%-439.06K
-175.50%-1.47M
-95.57%100.41K
978.75%121.23K
-348.00%-1.23M
Cash from discontinued investing activities
Operating cash flow
105.46%208.05K
14.55%-11.01M
8.13%-2.67M
19.72%-2.36M
38.75%-2.18M
-9.08%-3.81M
-71.38%-12.89M
-385.20%-2.9M
-11.52%-2.94M
-10.24%-3.55M
Investing cash flow
Cash flow from continuing investing activities
34.24%-24.42K
-104.54%-120.2K
26.37%-36.91K
-101.72%-14.8K
-101.72%-31.36K
-346.41%-37.13K
181.67%2.65M
98.35%-50.12K
1,687.03%860.71K
2,054.91%1.82M
Net PPE purchase and sale
34.24%-24.42K
68.09%-120.2K
26.37%-36.91K
89.37%-14.8K
82.15%-31.36K
-222.54%-37.13K
-36.84%-376.62K
24.27%-50.12K
-156.83%-139.29K
-88.27%-175.69K
Net investment purchase and sale
----
--0
--0
--0
----
----
201.92%3.03M
--0
--1M
--2M
Cash from discontinued investing activities
Investing cash flow
34.24%-24.42K
-104.54%-120.2K
26.37%-36.91K
-101.72%-14.8K
-101.72%-31.36K
-346.41%-37.13K
181.67%2.65M
98.35%-50.12K
1,687.03%860.71K
2,054.91%1.82M
Financing cash flow
Cash flow from continuing financing activities
-142.27%-509.33K
-1.75%7.27M
-51.00%2.54M
-0.02%1.56M
196.12%1.96M
7,768.90%1.21M
-38.46%7.4M
5.19M
1.56M
205,677.95%661.96K
Net common stock issuance
-100.91%-11.27K
-31.66%5.79M
-86.28%826.95K
1.52%1.64M
151.07%2.08M
--1.24M
-36.55%8.47M
--6.03M
--1.61M
--829.61K
Proceeds from stock option exercised by employees
----
--1.81M
----
----
----
----
--0
----
----
----
Net other financing activities
-1,221.18%-498.06K
68.93%-332.92K
88.49%-96.32K
-48.33%-76.19K
26.81%-122.71K
-139.92%-37.7K
19.26%-1.07M
---836.94K
---51.37K
-51,963.98%-167.65K
Cash from discontinued financing activities
Financing cash flow
-142.27%-509.33K
-1.75%7.27M
-51.00%2.54M
-0.02%1.56M
196.12%1.96M
7,768.90%1.21M
-38.46%7.4M
--5.19M
--1.56M
205,677.95%661.96K
Net cash flow
Beginning cash position
-72.57%1.46M
-34.78%5.32M
-47.46%1.62M
-32.41%2.43M
-42.56%2.68M
-34.78%5.32M
18.24%8.16M
-69.71%3.08M
-72.01%3.6M
-71.16%4.67M
Current changes in cash
87.67%-325.69K
-36.11%-3.86M
-107.14%-159.94K
-57.06%-814.68K
76.88%-246.33K
24.37%-2.64M
-325.41%-2.84M
210.96%2.24M
80.72%-518.71K
67.87%-1.07M
End cash Position
-57.69%1.13M
-72.57%1.46M
-72.57%1.46M
-47.46%1.62M
-32.41%2.43M
-42.56%2.68M
-34.78%5.32M
-34.78%5.32M
-69.71%3.08M
-72.01%3.6M
Free cash flow
104.77%183.63K
16.12%-11.13M
8.67%-2.7M
22.87%-2.38M
40.80%-2.21M
-9.78%-3.85M
-70.26%-13.27M
-411.09%-2.96M
-14.44%-3.08M
-12.44%-3.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 105.46%208.05K14.55%-11.01M8.13%-2.67M19.72%-2.36M38.75%-2.18M-9.08%-3.81M-71.38%-12.89M-385.20%-2.9M-11.52%-2.94M-10.24%-3.55M
Net income from continuing operations 153.37%1.79M-3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M-18.60%-11.86M-128.12%-3.14M-25.69%-3.47M-15.20%-3.52M
Operating gains losses ---389.45K----------------------32.14K------------
Depreciation and amortization 11.03%65.13K23.85%246.79K2.59%64.13K10.80%63.11K38.69%60.9K63.44%58.66K67.99%199.27K87.03%62.51K80.78%56.96K53.90%43.91K
Other non cash items 1,120.59%352.28K509.67%669.61K1,962.63%583K2.15%28.28K8.70%29.47K7.80%28.86K-48.23%109.83K-78.61%28.27K2.09%27.68K1.66%27.11K
Change In working capital -125.93%-1.94M60.69%-954.61K-87.68%-303.79K-115.04%-22.87K173.38%232.7K59.05%-860.65K-300.11%-2.43M-108.17%-161.87K179.58%152.04K29.75%-317.12K
-Change in receivables -303.44%-2.19M-631.44%-176.64K--233.92K-32.19%145.09K89.68%-12.24K-775.29%-543.4K120.13%33.24K--0484.82%213.95K-892.25%-118.63K
-Change in inventory 496.71%704.29K11.12%-908.47K-300.52%-841.72K-40.77%-481.76K209.69%296.98K159.31%118.03K-68.60%-1.02M16.02%-210.16K-47.27%-342.22K-3,854.20%-270.75K
-Change in prepaid assets 475.71%21.76K43.71%47.29K186.37%45.02K-8.03%146.3K0.80%-147.81K-94.96%3.78K122.61%32.9K-66,719.23%-52.12K758.57%159.08K16.12%-149K
-Change in payables and accrued expense -8.92%-478.23K105.65%83.21K157.94%259K38.16%167.5K107.76%95.76K4.60%-439.06K-175.50%-1.47M-95.57%100.41K978.75%121.23K-348.00%-1.23M
Cash from discontinued investing activities
Operating cash flow 105.46%208.05K14.55%-11.01M8.13%-2.67M19.72%-2.36M38.75%-2.18M-9.08%-3.81M-71.38%-12.89M-385.20%-2.9M-11.52%-2.94M-10.24%-3.55M
Investing cash flow
Cash flow from continuing investing activities 34.24%-24.42K-104.54%-120.2K26.37%-36.91K-101.72%-14.8K-101.72%-31.36K-346.41%-37.13K181.67%2.65M98.35%-50.12K1,687.03%860.71K2,054.91%1.82M
Net PPE purchase and sale 34.24%-24.42K68.09%-120.2K26.37%-36.91K89.37%-14.8K82.15%-31.36K-222.54%-37.13K-36.84%-376.62K24.27%-50.12K-156.83%-139.29K-88.27%-175.69K
Net investment purchase and sale ------0--0--0--------201.92%3.03M--0--1M--2M
Cash from discontinued investing activities
Investing cash flow 34.24%-24.42K-104.54%-120.2K26.37%-36.91K-101.72%-14.8K-101.72%-31.36K-346.41%-37.13K181.67%2.65M98.35%-50.12K1,687.03%860.71K2,054.91%1.82M
Financing cash flow
Cash flow from continuing financing activities -142.27%-509.33K-1.75%7.27M-51.00%2.54M-0.02%1.56M196.12%1.96M7,768.90%1.21M-38.46%7.4M5.19M1.56M205,677.95%661.96K
Net common stock issuance -100.91%-11.27K-31.66%5.79M-86.28%826.95K1.52%1.64M151.07%2.08M--1.24M-36.55%8.47M--6.03M--1.61M--829.61K
Proceeds from stock option exercised by employees ------1.81M------------------0------------
Net other financing activities -1,221.18%-498.06K68.93%-332.92K88.49%-96.32K-48.33%-76.19K26.81%-122.71K-139.92%-37.7K19.26%-1.07M---836.94K---51.37K-51,963.98%-167.65K
Cash from discontinued financing activities
Financing cash flow -142.27%-509.33K-1.75%7.27M-51.00%2.54M-0.02%1.56M196.12%1.96M7,768.90%1.21M-38.46%7.4M--5.19M--1.56M205,677.95%661.96K
Net cash flow
Beginning cash position -72.57%1.46M-34.78%5.32M-47.46%1.62M-32.41%2.43M-42.56%2.68M-34.78%5.32M18.24%8.16M-69.71%3.08M-72.01%3.6M-71.16%4.67M
Current changes in cash 87.67%-325.69K-36.11%-3.86M-107.14%-159.94K-57.06%-814.68K76.88%-246.33K24.37%-2.64M-325.41%-2.84M210.96%2.24M80.72%-518.71K67.87%-1.07M
End cash Position -57.69%1.13M-72.57%1.46M-72.57%1.46M-47.46%1.62M-32.41%2.43M-42.56%2.68M-34.78%5.32M-34.78%5.32M-69.71%3.08M-72.01%3.6M
Free cash flow 104.77%183.63K16.12%-11.13M8.67%-2.7M22.87%-2.38M40.80%-2.21M-9.78%-3.85M-70.26%-13.27M-411.09%-2.96M-14.44%-3.08M-12.44%-3.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+5.46%
Lennar Corp
LEN
-0.95%
Adobe
ADBE
-0.98%
Apple
AAPL
-1.27%
Vale SA
VALE
-1.33%

Unlock the Full List